Seven DLBCL Proteogenotypes Reveal Hidden High-Risk Subtype Beyond Standard Markers
For patients diagnosed with diffuse large B cell lymphoma, standard molecular classification still leaves a significant proportion with unexplained treatment f…
Found 1467 results for "cancer"
For patients diagnosed with diffuse large B cell lymphoma, standard molecular classification still leaves a significant proportion with unexplained treatment f…
For the millions of cancer patients who lose dangerous amounts of muscle mass during treatment, cachexia represents one of oncology's most intractable problems…
Early cancer interception—stopping a tumor before it becomes one—has long been hampered by the inability to identify who is actually on that trajectory. A bloo…
Knowing in advance whether a patient will respond to immunotherapy could spare them months of ineffective treatment and serious side effects — yet current biom…
For the millions of adults navigating cancer treatment, cardiovascular complications are already a leading cause of morbidity — yet a largely invisible class o…
For the boys who survive childhood cancer, the victory often carries a hidden cost: permanent infertility caused by treatment that obliterates the testicular s…
Screening algorithms are only as equitable as the data and assumptions baked into them. When the tools used to decide who gets a lung cancer scan perform diffe…
For patients whose cancers have stopped responding to chemotherapy or immunotherapy, the search for new vulnerabilities in tumor cells is urgent. A growing bod…
Equal equipment availability doesn't mean equal access — and for women in economically disadvantaged neighborhoods, the difference may show up most acutely in…
For postmenopausal women — a demographic already navigating elevated cardiovascular and metabolic risk — the combination of how much they move and how long the…
Rapid pharmacologic weight loss from tirzepatide — a dual GIP/GLP-1 receptor agonist — reduces breast volume and subcutaneous fat, making pre-existing benign l…
Pancreatic cancer remains one of oncology's most stubborn challenges, largely because tumor cells have evolved sophisticated molecular defenses against DNA-dam…
Every time a cancer cell spreads to a distant organ or an immune cell hunts down a pathogen, it must perform a feat of physical engineering: forcing its nucleu…
The oral cavity is far more than a gateway for food and microbes — it is an immunological frontier where specialized sentinel cells maintain a delicate truce b…
Cancer biology has long treated p53 as a straightforward tumor suppressor—a molecular brake that halts runaway cell growth. New evidence now complicates that n…
One of the most stubborn barriers in precision medicine has been the inability to deploy antibody therapies against proteins that operate inside cells — where…
For anyone who has undergone chemotherapy, radiation, or inflammatory bowel disease flares, the gut's ability to regenerate its lining is not an abstract conce…
Accurate diagnosis of rare congenital conditions often hinges on highly specialized expertise that most clinical settings simply lack — and that diagnostic gap…
For the roughly 80,000 Americans diagnosed with kidney cancer each year, surgery remains the primary treatment — yet a significant proportion face recurrence w…
Sarcopenia management is converging on a multi-modal clinical framework, with protein thresholds of 1.2–1.5 g/kg/day, β-hydroxy-β-methylbutyrate (HMB), and leu…